Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VPAP III

K-Number: K030843 · 2003-08-15

ApplicantResmed, Ltd.
Decision Date2003-08-15
Product CodeBZD
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

VPAP III is the device name listed in this FDA 510(k) record. The listed applicant is Resmed, Ltd.. It received FDA 510(k) clearance on 2003-08-15 under 510(k) number K030843. The device is classified under product code BZD. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VPAP III?

VPAP III is a medical device that received FDA 510(k) clearance on 2003-08-15. The listed applicant is Resmed, Ltd.. The 510(k) number is K030843.

When did VPAP III receive FDA 510(k) clearance?

VPAP III received FDA 510(k) clearance on 2003-08-15, under 510(k) number K030843.

Who is the listed applicant for VPAP III?

The FDA 510(k) record lists Resmed, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VPAP III?

The FDA product code for VPAP III is BZD.

Other records listing Resmed, Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 95 devices →

Related Devices (Code: BZD)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑